Study reveals that coffee consumption is associated with a reduced risk of developing irritable bowel syndrome (IBS), as determined by a systematic review and meta-analysis of global studies.
Novo Nordisk, Valo to develop cardiometabolic disease therapies
Novo Nordisk will license three preclinical drug discovery programmes developed using Valo’s platform. Credit: Novo Nordisk. Novo Nordisk has signed an agreement with Valo Health for the